TuHURA Biosciences, Inc. (HURA) Stock
Healthcare · Biotechnology · US
$2.57
+15.77%
Last updated Jun 18, 2026 23:56 UTC
HURA Key Statistics
Market Cap$163.66M
P/E (TTM)-4.21
P/S (TTM)—
P/B (TTM)6.65
Revenue (TTM)$0.00
EPS (TTM)$-0.61
Dividend Yield—
ROE (TTM)-153.99%
Net Margin0.00%
Gross Margin0.00%
52W High$3.90
52W Low$0.41
Analyst ViewBuy
Price Target—
Employees19
Volume1,078,626
About TuHURA Biosciences, Inc.
TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registration stage of clinical development. The company is dedicated to pioneering innovative technologies designed to effectively combat the mechanisms by which cancers develop resistance to existing immunotherapy treatments. Its operations are based in Tampa, Florida.
CEO: James A. Bianco. Company website
See HURA live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open HURA in Terminal See plans